loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Difluprednate

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Difluprednate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 93,669Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Adverum Presents Positive Ixo-vec Data At ASRS Meeting
    Adverum Presents Positive Ixo-vec Data At ASRS Meeting

    17 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/17/2914283/32452/en/Adverum-Biotechnologies-Presents-Positive-Ixo-vec-Clinical-Data-from-the-26-Week-Interim-Analysis-of-the-LUNA-Phase-2-Trial-at-the-2024-ASRS-Annual-Meeting.html

    GLOBENEWSWIRE
    17 Jul 2024
    Share Share
    Epic Pharma's Generic Difluprednate Receives Approval in the U.S
    Epic Pharma's Generic Difluprednate Receives Approval in the U.S

    14 May 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207284

    FDA
    14 May 2024
    Share Share
    Dr. Reddy's announces the launch of Difluprednate Ophthalmic Emulsion 0.05%
    Dr. Reddy's announces the launch of Difluprednate Ophthalmic Emulsion 0.05%

    28 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230127005193/en

    BUSINESSWIRE
    28 Jan 2023
    Share Share
    Dr. Reddy's Generic Difluprednate Receives Approval in the U.S.
    Dr. Reddy's Generic Difluprednate Receives Approval in the U.S.

    16 Nov 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214894

    FDA
    16 Nov 2022
    Share Share
    Enforcement Report - Week of September 14, 2022
    Enforcement Report - Week of September 14, 2022

    14 Sep 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-14-2022-34762.pdf

    FDA
    14 Sep 2022
    Share Share
    Enforcement Report - Week of August 17, 2022
    Enforcement Report - Week of August 17, 2022

    17 Aug 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-17-2022-1660735823.pdf

    FDA
    17 Aug 2022
    Share Share